| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |